JPMorgan lowered the firm’s price target on Zoetis (ZTS) to $200 from $230 and keeps an Overweight rating on the shares post the Q3 report. The firm reduced estimates to reflect slower growth in 2025 and 2026 but says this is already priced into the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS: